CSPC Pharmaceutical Group Limited (HKG:1093)

CSPC Pharmaceutical Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 18, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	86,662	96,380	55,169	86,022	97,707	100,932
Market Cap Growth	22.98%	74.70%	-35.87%	-11.96%	-3.19%	6.47%
Enterprise Value	77,359	88,081	45,415	74,600	84,557	88,212
Last Close Price	7.58	8.43	4.65	6.73	7.30	7.35
PE Ratio	20.05	22.31	11.98	13.30	14.19	14.67
Forward PE	11.83	17.08	9.76	12.05	13.86	15.70
PS Ratio	2.99	3.33	1.79	2.48	2.79	2.95
PB Ratio	2.25	2.51	1.53	2.23	2.73	3.07
P/TBV Ratio	2.57	2.86	1.76	2.53	3.08	3.24
P/FCF Ratio	20.11	22.37	20.58	30.56	15.99	25.49
P/OCF Ratio	13.35	14.85	11.43	18.68	11.33	17.73
PEG Ratio	0.92	1.96	1.10	1.30	1.25	1.25
EV/Sales Ratio	2.67	3.04	1.47	2.15	2.42	2.58
EV/EBITDA Ratio	13.29	15.49	6.62	8.53	9.83	10.31
EV/EBIT Ratio	17.79	19.98	7.95	9.65	11.07	11.50
EV/FCF Ratio	17.95	20.44	16.94	26.50	13.83	22.27
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.02	0.00
Debt / EBITDA Ratio	0.12	0.12	0.08	0.09	0.08	0.01
Debt / FCF Ratio	0.17	0.17	0.20	0.28	0.11	0.03
Net Debt / Equity Ratio	-0.28	-0.28	-0.25	-0.37	-0.44	-0.42
Net Debt / EBITDA Ratio	-1.90	-1.90	-1.34	-1.65	-1.84	-1.61
Net Debt / FCF Ratio	-2.51	-2.51	-3.42	-5.11	-2.59	-3.47
Asset Turnover	0.57	0.57	0.64	0.71	0.81	0.86
Inventory Turnover	2.88	2.88	2.78	3.26	3.45	3.10
Quick Ratio	1.88	1.88	1.95	2.32	2.39	2.47
Current Ratio	2.19	2.19	2.27	2.63	2.67	2.81
Return on Equity (ROE)	11.33%	11.33%	12.60%	18.22%	21.32%	22.79%
Return on Assets (ROA)	5.44%	5.44%	7.40%	9.96%	11.04%	12.05%
Return on Invested Capital (ROIC)	12.65%	12.76%	17.69%	29.11%	33.40%	34.94%
Return on Capital Employed (ROCE)	10.80%	10.80%	15.40%	19.40%	20.60%	22.70%
Earnings Yield	4.98%	4.48%	8.35%	7.52%	7.05%	6.82%
FCF Yield	4.97%	4.47%	4.86%	3.27%	6.26%	3.92%
Dividend Yield	3.73%	3.44%	5.45%	4.22%	2.96%	2.54%
Payout Ratio	64.33%	64.33%	74.72%	46.42%	34.42%	30.16%
Buyback Yield / Dilution	2.68%	2.68%	1.14%	0.38%	0.29%	0.01%
Total Shareholder Return	6.41%	6.12%	6.59%	4.60%	3.25%	2.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.